FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Reserpine Tablets
Status: Discontinuation
»Therapeutic Categories: Cardiovascular; Pediatric

Expand all

Sandoz (Revised 08/30/2016)

Company Contact Information:
800-525-8747

Presentation Posting Date Related Information
0.25 mg 100s (NDC 0185-0134-01) N/A Permanent discontinuation
0.25 mg 1000s (NDC 0185-0134-10) N/A Permanent discontinuation
0.1 mg 100s (NDC 0185-0032-01) N/A Permanent discontinuation
0.1 mg 1000s (NDC 0185-0032-10) N/A Permanent discontinuation

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English